Details of the Drug

General Information of Drug (ID: DM4JL1R)

Drug Name

Hib-MenCY-TT vaccine

Indication

Disease Entry	ICD 11	Status	REF
Meningitis	1D01	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01978093) Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age. U.S. National Institutes of Health.